Patent US1919916A successfully refreshed from Google Patents.
Patent US4267274A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4267274A Expired / Lapsed US ⏱️ 0.0 years remaining

Streptomyces mediterranei mutant capable of production of rifamycin B

Assignee: Gruppo Lepetit SpA
•
Filing: 1974-06-13
•
Granted: 1981-05-12
•
Expires: 1994-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biologically pure culture of Streptomyces mediterranei mutant strain 18, ATCC.

Inventors

  • 👤 Richard J. White
  • 👤 Giancarlo Lancini

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 08:07
CPC Classifications
C; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P17/00; C12P17/18; C12P17/188; C12P17/189; C12R; C12R2001/00; C12R2001/01; C12R2001/465; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/886

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 50 words
A biologically pure culture comprising a new microorganism mutant identified as Streptomyces mediterranei M 18, ATCC 21789, and a nutrient medium consisting essentially of an assimilable carbon source, an assimilable nitrogen source and essential mineral salts, said culture being capable of producing rifamycin B in a recoverable quantity upon fermentation.
Claim 2
Dependent Claim 50 words
A biologically pure culture comprising a new microorganism mutant identified as Streptomyces mediterranei M 18, ATCC 21789, and a nutrient medium consisting essentially of an assimilable carbon source, an assimilable nitrogen source and essential mineral salts, said culture being capable of producing rifamycin B in a recoverable quantity upon fermentation.
Claim 3
Dependent Claim 23 words
A biologically pure culture of Streptomyces mediterranei, mutant strain 18, (ATCC 21789) capable of producing rifamycin B in a recoverable quantity upon fermentation.
Claim 4
Dependent Claim 23 words
A biologically pure culture of Streptomyces mediterranei, mutant strain 18, (ATCC 21789) capable of producing rifamycin B in a recoverable quantity upon fermentation.

References Cited (Backward Citations)

US3150046A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-05-11 1984-11-10 1985-05-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-05-11 1988-11-10 1989-05-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-05-11 1992-11-10 1993-05-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag